Loading...
6 results
Search Results
Now showing 1 - 6 of 6
- Advances in time course extracellular production of human pre-miR-29b from Rhodovulum sulfidophilumPublication . Pereira, Patrícia; Pedro, Augusto; Tomás, Joana; Baptista, Cláudio; Queiroz, João; Figueiras, Ana; Sousa, FaniThe present study reports the successful production of human pre-miR-29b both intra- and extracellularly in the marine phototrophic bacterium Rhodovulum sulfidophilum using recombinant RNA technology. In a first stage, the optimal transformation conditions (0.025 μg of plasmid DNA, with a heat-shock of 2 min at 35 °C) were established, in order to transfer the pre-miR-29b encoding plasmid to R. sulfidophilum host. Furthermore, the extracellular recovery of this RNA product from the culture medium was greatly improved, achieving quantities that are compatible with the majority of applications, namely for in vitro or in vivo studies. Using this system, the extracellular human pre-miR-29b concentration was approximately 182 μg/L, after 40 h of bacterial growth, and the total intracellular pre-miR-29b was of about 358 μg/L, at 32 h. At the end of the fermentation, it was verified that almost 87 % of cells were viable, indicating that cell lysis is minimized and that the extracellular medium is not highly contaminated with the host intracellular ribonucleases (RNases) and endotoxins, which is a critical parameter to guarantee the microRNA (miRNA) integrity. These findings demonstrate that pre-miRNAs can be produced by recombinant RNA technology, offering novel clues for the production of natural pre-miRNA agents for functional studies and RNA interference (RNAi)-based therapeutics.
- HPV-16 targeted DNA vaccine expression: The role of purificationPublication . Almeida, Ana Margarida; Tomás, Joana; Pereira, Patrícia; Queiroz, João; Sousa, Fani; Sousa, ÂngelaDNA vaccines have come to light in the last decades as an alternative method to prevent many infectious diseases, but they can also be used for the treatment of specific diseases, such as cervical cancer caused by Human Papillomavirus (HPV). This virus produces E6 and E7 oncoproteins, which alter the cell cycle regulation and can interfere with the DNA repairing system. These features can ultimately lead to the progression of cervical cancer, after cell infection by HPV. Thus, the development of a DNA vaccine targeting both proteins arises as an interesting option in the treatment of this pathology. Nonetheless, before evaluating its therapeutic potential, the purity levels of a biopharmaceutical must meet the regulatory agency specifications. Previously, our research group successfully purified the supercoiled isoform of the recombinant HPV-16 E6/E7 DNA vaccine with virtual 100% purity by affinity chromatography. The present work was designed to evaluate the effect that pDNA sample purity levels may exert in the expression of a target protein. Thus, in vitro studies were performed to assess the vaccine ability to produce the target proteins and to compare the expression efficiency between the pDNA sample obtained by affinity chromatography, which only presents the sc isoform and fulfils the regulatory agency recommendations, and the same DNA vaccine retrieved by a commercial purification kit, which contains different pDNA isoforms. Our achievements suggest that the E6/E7 DNA vaccine purified by affinity chromatography promotes higher E6 and E7 mRNA and protein expression levels than the DNA vaccine purified with the commercial kit. Overall, these results underline the importance that a purification strategy may present in the therapeutic outcome of recombinant DNA vaccines, envisaging their further application as biopharmaceuticals. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 34:546-551, 2018.
- Taste receptors in the Choroid Plexus are functional and regulated by sex hormonesPublication . Tomás, Joana Filipa Melfe; Gonçalves, Isabel Maria Theriaga Mendes Varanda; Santos, Cecília Reis Alves dosThe choroid plexuses (CPs) are highly vascularized structures constituted by a single layer of epithelial cells that project into the brain ventricles. The CPs are the main site of cerebrospinal fluid (CSF) production and constitute the Blood-CSF Barrier (BCSFB), holding high relevance in the surveillance of the CSF chemical composition. These structures contribute for the synthesis of biological compounds essential for the functioning and protection of the central nervous system (CNS) against neurotoxic insults. The expression of taste signalling pathway components in the CPs and its regulation by sex hormones was previously determined in a cDNA microarray study previously performed by our group. Moreover, the taste signalling pathway was determined as one as the top five pathways regulated by female sex hormones. The ectopic expression of sweet, umami and bitter taste signalling in extra oral organs have been extensively studied. In these organs, the taste receptors seems to behave as sensors to assess the composition of body fluids. The expression of the taste molecular machinery and its putative regulation by sex hormones in the CP raised the hypothesis that the taste signalling pathway could be one of the mechanisms involved in the monitoring of the chemical composition of blood and CSF at the BCSFB that my differ with gender. Considering this, we aimed to evaluate the presence and the functionality of the taste signalling pathway, as well as its regulation by the female sex hormones 17β-estradiol (E2) and progesterone (P4) in rat CP. In the first study, the presence and functionality of the taste signalling pathway was assessed. Transcripts for the taste-related genes Tas1r1, Tas1r2, Tas1r3, Tas2r109, Tas2r144, Gustducin, Plcb2, Ip3R3 and TrpM5 were found in CPs from adult Wistar rats. The expression of Tas1r1, Tas1r2, Tas2r144, Gustducin, Plcb2 and TrpM5 proteins was confirmed by Western blot, immunohistochemistry and immunocytochemistry. As umami and sweet receptors are heterodimeric receptors, we performed double labelling immunofluorescence, that showed the co-expression of T1R1 and T1R3 proteins that form the umami receptor, as well as, the coexpression of T1R2 and T1R3 proteins that form the sweet receptor. Having established the cellular localization of the taste machinery in CP epithelial cells (CPEC) we further evaluated the subcellular expression of taste proteins. For that, CPs were double labelled with antibodies for each of the taste-related proteins studied and a fluorescent marker of glycosylated surfaceexpressed proteins, revealing that taste-related proteins are located in the plasma membrane. After confirming the presence of the taste pathway molecular machinery, we proceed with functional assays. Considering that most of toxic/noxious compounds are bitter compounds that may exist in the CSF, we turned our attention to the bitter taste signalling pathway. Thus, to evaluate the functionality of the bitter pathway in primary cultures of CPEC we performed single cell calcium imaging assays using D-Salicin as the bitter stimulus. We observed an increase in intracellular Ca2+ evoked by D-Salicin that was diminished in the presence of the bitter taste receptors (T2Rs) blocker Probenecid, suggesting that T2R in the CPs are capable of sensing bitter compounds in the CSF and/or blood. An analysis in silico of our previous cDNA microarray data revealed that the decline of hormone levels in female rats upon ovariectomy clearly induced an up-regulation of the T2Rs Tas2r109, Tas2r124, Tas2r134, and Tas2r144, and the downstream effector molecules Plcb2 and Trpm5. Moreover, Tas2r109 and Tas2r144 were differentially expressed between female and male, showing a higher expression in males. This data led us to the second study of these thesis where the regulation of the taste pathway by female sex hormones was analyzed. For that, we compared the expression of taste-related genes in the CPs of sham and ovariectomized female Wistar rats and in CPs explants from newborn rats incubated with different concentrations of E2 and/or P4. Our results confirmed the cDNA microarray data, corroborating the regulation of taste-related genes by E2 and P4. The bitter receptors Tas2r109, Tas2r144, and the tasterelated genes Plcb2 and Trpm5 were down-regulated by ovarian hormones both in vivo and ex vivo. Functional implications of female sex hormones regulation was assessed, by single cell Ca2+ imaging, with the bitter compound, Denatonium Benzoate (DB), which is a known ligand of Tas2r144. Single cell Ca2+ imaging was performed in the immortalized CP epithelial cell line Z310 incubated with E2 and/or P4 in the presence of the respective hormone receptor blocker (fulvestrant or mifepristone, respectively). Intracellular Ca2+ variation, observed by single cell calcium imaging, was diminished in the presence of female sex hormones. However, while E2 effects were mediated via the nuclear E2 receptor, P4 effects were not abolished by the blocker of nuclear P4 receptor. Knocking-down Tas2r144 with a specific siRNA effectively reduced the Ca2+ response to the bitter compound DB, in a similar manner to E2 and P4, suggesting that female sex hormones down-regulated the responses of CPEC to chemical stimuli by reducing Tas2r144. In summary, our results confirmed and characterized the presence and functionality of the taste signalling machinery in CPs showing its regulation by female sex hormones. These results suggest that the taste signalling pathway may be one of the mechanisms by which the CP surveys the chemical composition of the CSF and elicit responses to modulate and maintain brain homeostasis. The achievements reached with this work will contribute to a better understanding of the mechanisms underlying the sensor/protective role of CPs in the CNS.
- Androgen receptor alternative spliced transcripts: tissue expression and evolutionary analysisPublication . Tomás, Joana Filipa Melfe; Socorro, Sílvia Cristina da Cruz Marques; Cavaco, José Eduardo BritesThe vast majority of human genes express multiple mRNAs by alternative splicing of their pre-mRNAs. This mechanism allows the expression of many different mRNAs from the same gene, and greatly increases the complexity of “cell-specific” protein function. It can alter the function of proteins by removing or adding specific domains (nuclear localization signals, transcription activation domains, DNA or RNA binding domains, trans-membrane domains), post-translation modification sites, or by causing substantial changes in protein structure. The existence of several variant RNA transcripts has been described for many steroid receptors. However, the information on alternative spliced mRNAs of androgen receptor (AR) gene is scarce. A previous work in our research group (Laurentino et al. 2006, results not published) allowed the identification for the first time of AR alternative transcripts in human testis. Two transcripts result from exon 2 (ARΔ2) and exon 3 (ARΔ3) skipping. Transcripts lacking exon 2 but retaining part of intron 2 of the AR gene (AR55), and lacking part of exon 4 (AR94) were also detected. The aims of the present study are: 1) characterize the distribution of AR transcripts in different human tissues (heart, kidney, liver, and lung); 2) perform an evolutionary analysis by characterizing the expression of AR transcripts in testis of chicken (Gallus gallus), dog (Cannis lupus), rat (Rattus norvegicus) and sea bream (Sparus aurata). For this purpose the following experimental approach was established: 1) exon spanning primers suitable for the detection of alternative spliced ARs were designed; 2) Total RNA was extracted and used for cDNA synthesis; 3) RTPCR was carried out and the amplified products were cloned and sequenced; 4) the obtained sequences were analysed using bioinformatics tools. In human heart, kidney, liver and lung was observed the presence of ARΔ2 and ARΔ3 transcripts previously identified in testis. In seabream, rat and dog testis were detected several AR transcripts some of which are homologous to those identified in human testis.
- Brain-Targeted Delivery of Pre-miR-29b Using Lactoferrin-Stearic Acid-Modified-Chitosan/Polyethyleneimine PolyplexesPublication . Pereira, Patrícia; Barreira, Maria; Cruz, Carla; Tomás, Joana; Luís, Ângelo; Pedro, Augusto; Queiroz, João; Sousa, FaniThe efficacy of brain therapeutics is largely hampered by the presence of the blood-brain barrier (BBB), mainly due to the failure of most (bio) pharmaceuticals to cross it. Accordingly, this study aims to develop nanocarriers for targeted delivery of recombinant precursor microRNA (pre-miR-29b), foreseeing a decrease in the expression of the BACE1 protein, with potential implications in Alzheimer's disease (AD) treatment. Stearic acid (SA) and lactoferrin (Lf) were successfully exploited as brain-targeting ligands to modify cationic polymers (chitosan (CS) or polyethyleneimine (PEI)), and its BBB penetration behavior was evaluated. The intracellular uptake of the dual-targeting drug delivery systems by neuronal cell models, as well as the gene silencing efficiency of recombinant pre-miR-29b, was analyzed in vitro. Labeled pre-miR-29b-CS/PEI-SA-Lf systems showed very strong fluorescence in the cytoplasm and nucleus of RBE4 cells, being verified the delivery of pre-miR-29b to neuronal cells after 1 h transfection. The experiment of transport across the BBB showed that CS-SA-Lf delivered 65% of recombinant pre-miR-29b in a period of 4 h, a significantly higher transport ratio than the 42% found for PEI-SA-Lf in the same time frame. Overall, a novel procedure for the dual targeting of DDS is disclosed, opening new perspectives in nanomedicines delivery, whereby a novel drug delivery system harvests the merits and properties of the different immobilized ligands.
- Adenosine inhibits human astrocyte proliferation independently of adenosine receptor activationPublication . Marcelino, Helena; Nogueira, Vanda Cristina Simões; Santos, Cecilia; Quelhas, Patricia; Carvalho, Tiago; Gomes, João Fonseca; Tomás, Joana; Diógenes, Maria José; Sebastião, Ana M; Cascalheira, JoséBrain adenosine concentrations can reach micromolar concentrations in stressful situations such as stroke, neurodegenerative diseases or hypoxic regions of brain tumours. Adenosine can act by receptor-independent mechanism by reversing the reaction catalysed by S-adenosylhomocysteine (SAH) hydrolase, leading to SAH accumulation and inhibition of S-adenosylmethionine (SAM)-dependent methyltransferases. Astrocytes are essential in maintaining brain homeostasis but their pathological activation and uncontrolled proliferation plays a role in neurodegeneration and glioma. Adenosine can affect cell proliferation, but the effect of increased adenosine concentration on proliferation of astrocytes is not clarified and was addressed in present work. Human astrocytes (HA) were treated for 3 days with test drugs. Cell proliferation/viability was assessed by the MTT assay and by cell counting. Cell death was evaluated by assessing lactate dehydrogenase (LDH) release and by western blot analysis of αII-Spectrin cleavage. 30µM-Adenosine caused a 40%±3% (p < .05, n = 5) reduction in cell proliferation/viability, an effect reversed by 2U/ml-adenosine deaminase, but unchanged in the presence of antagonists of any of the adenosine receptors. Adenosine alone did not induce cell death. 100µM-Homocysteine alone caused 16%±3% (p < .05) decrease in HA proliferation. Combined action of adenosine and homocysteine decreased HA proliferation by 76%±4%, an effect higher (p < .05) than the sum of the effect of adenosine and homocysteine alone (56%±5%). The inhibitory effect of adenosine on HA proliferation/viability was mimicked by two adenosine kinase inhibitors and attenuated in the presence of folate (100µM) or SAM (50-100µM). The results suggest that adenosine reduces HA proliferation by a receptor-independent mechanism probably involving reversal of SAH hydrolase-catalysed reaction.